AEMD Quote, Financials, Valuation and Earnings

InfuSystem Holdings, Inc. has a net margin of -- compared to Aethlon Medical, Inc.'s net margin of 6.19%. Aethlon Medical, Inc.'s return on equity of -228.41% beat InfuSystem Holdings, Inc.'s return on equity of 9.93%.

Aethlon Medical, Inc. has a consensus price target of $12.38, signalling upside risk potential of 366.98%. On the other hand InfuSystem Holdings, Inc. has an analysts' consensus of $14.20 which suggests that it could grow by 75.09%. Given that Aethlon Medical, Inc. has higher upside potential than InfuSystem Holdings, Inc., analysts believe Aethlon Medical, Inc. is more attractive than InfuSystem Holdings, Inc..

Aethlon Medical, Inc. has a beta of 1.596, which suggesting that the stock is 59.559% more volatile than S&P 500. In comparison InfuSystem Holdings, Inc. has a beta of 1.680, suggesting its more volatile than the S&P 500 by 68.01%.

Aethlon Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InfuSystem Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aethlon Medical, Inc. pays -- of its earnings as a dividend. InfuSystem Holdings, Inc. pays out -- of its earnings as a dividend.

Aethlon Medical, Inc. quarterly revenues are --, which are smaller than InfuSystem Holdings, Inc. quarterly revenues of $36.5M. Aethlon Medical, Inc.'s net income of -$1.5M is lower than InfuSystem Holdings, Inc.'s net income of $2.3M. Notably, Aethlon Medical, Inc.'s price-to-earnings ratio is -- while InfuSystem Holdings, Inc.'s PE ratio is 31.01x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aethlon Medical, Inc. is -- versus 1.22x for InfuSystem Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX Ltd. has a net margin of -- compared to Aethlon Medical, Inc.'s net margin of -862.39%. Aethlon Medical, Inc.'s return on equity of -228.41% beat VolitionRX Ltd.'s return on equity of --.

Aethlon Medical, Inc. has a consensus price target of $12.38, signalling upside risk potential of 366.98%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.20 which suggests that it could grow by 746.15%. Given that VolitionRX Ltd. has higher upside potential than Aethlon Medical, Inc., analysts believe VolitionRX Ltd. is more attractive than Aethlon Medical, Inc..

Aethlon Medical, Inc. has a beta of 1.596, which suggesting that the stock is 59.559% more volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.234, suggesting its more volatile than the S&P 500 by 23.404%.

Aethlon Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aethlon Medical, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.

Aethlon Medical, Inc. quarterly revenues are --, which are smaller than VolitionRX Ltd. quarterly revenues of $627.3K. Aethlon Medical, Inc.'s net income of -$1.5M is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, Aethlon Medical, Inc.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aethlon Medical, Inc. is -- versus 17.82x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision, Inc. has a net margin of -- compared to Aethlon Medical, Inc.'s net margin of -1037.17%. Aethlon Medical, Inc.'s return on equity of -228.41% beat Catheter Precision, Inc.'s return on equity of -192.05%.

Aethlon Medical, Inc. has a consensus price target of $12.38, signalling upside risk potential of 366.98%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 1718.24%. Given that Catheter Precision, Inc. has higher upside potential than Aethlon Medical, Inc., analysts believe Catheter Precision, Inc. is more attractive than Aethlon Medical, Inc..

Aethlon Medical, Inc. has a beta of 1.596, which suggesting that the stock is 59.559% more volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.392, suggesting its less volatile than the S&P 500 by 239.195%.

Aethlon Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aethlon Medical, Inc. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.

Aethlon Medical, Inc. quarterly revenues are --, which are smaller than Catheter Precision, Inc. quarterly revenues of $226K. Aethlon Medical, Inc.'s net income of -$1.5M is higher than Catheter Precision, Inc.'s net income of -$2.3M. Notably, Aethlon Medical, Inc.'s price-to-earnings ratio is -- while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aethlon Medical, Inc. is -- versus 9.83x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of -- compared to Aethlon Medical, Inc.'s net margin of 3.93%. Aethlon Medical, Inc.'s return on equity of -228.41% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

Aethlon Medical, Inc. has a consensus price target of $12.38, signalling upside risk potential of 366.98%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 136.22%. Given that Aethlon Medical, Inc. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe Aethlon Medical, Inc. is more attractive than Xtant Medical Holdings, Inc..

Aethlon Medical, Inc. has a beta of 1.596, which suggesting that the stock is 59.559% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.077, suggesting its less volatile than the S&P 500 by 107.701%.

Aethlon Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aethlon Medical, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

Aethlon Medical, Inc. quarterly revenues are --, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Aethlon Medical, Inc.'s net income of -$1.5M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Aethlon Medical, Inc.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 62.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aethlon Medical, Inc. is -- versus 0.69x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.